Development of a points to consider document for human somatic cell gene therapy.
作者信息
Milewski E A
出版信息
Recomb DNA Tech Bull. 1985 Dec;8(4):176-80.
PMID:3867980
Abstract
摘要
相似文献
1
Development of a points to consider document for human somatic cell gene therapy.
Recomb DNA Tech Bull. 1985 Dec;8(4):176-80.
2
Points to consider in the design and submission of human somatic cell gene therapy protocols.人类体细胞基因治疗方案设计与提交时需考虑的要点。
Recomb DNA Tech Bull. 1985 Dec;8(4):181-6.
3
National Institutes of Health. Points to consider in the design and submission of human somatic-cell gene therapy protocols. Human Gene Therapy Subcommittee, NIH Recombinant DNA Advisory Committee. Adopted September 29, 1986.美国国立卫生研究院。人类体细胞基因治疗方案设计与提交中需考虑的要点。人类基因治疗小组委员会，美国国立卫生研究院重组DNA咨询委员会。1986年9月29日通过。
Recomb DNA Tech Bull. 1986 Dec;9(4):221-42.
4
Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee, Points to Consider Subcommittee. Minutes of meeting, March 31, 1989.卫生与公众服务部，公共卫生服务局，国立卫生研究院。重组DNA咨询委员会，要点审议小组委员会。1989年3月31日会议记录。
Recomb DNA Tech Bull. 1989 Sep;12(3):151-70.
5
Special informed consent requirements are included in protocol review procedures.方案审查程序中包含特殊的知情同意要求。
Hum Res Rep. 1995 Jul;10(7):1-2.
6
Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee. Minutes of meeting, January 30, 1989.
Recomb DNA Tech Bull. 1989 Jun;12(2):69-134.
7
Gene therapy guidelines approved.
Science. 1985 Oct 18;230(4723):302.
8
9
Gene therapy: proceed with caution.
Hastings Cent Rep. 1984 Apr;14(2):13-7.
10
Ethical issues in human gene therapy.
J Clin Ethics. 1991 Winter;2(4):267-74; discussion 274-8.
引用本文的文献
1
Governing Heritable Human Genome Editing: A Textual History and a Proposal for the Future.治理可遗传的人类基因组编辑：文本历史与未来建议。
CRISPR J. 2021 Aug;4(4):469-476. doi: 10.1089/crispr.2021.0043.
Zotero 插件